InvestSMART

Vitrafy Life Sciences Limited (ASX:VFY)

ALERT: Price-sensitive ASX Announcement for VFY
Current share price for VFY : $3.860 1.1 (39.86%)+
Announcement
Release
19 Jun 2026 8:20AM
Price at Release
$2.760
Full Release
download
Summary
Vitrafy Life Sciences Limited has announced a Share Purchase Plan (SPP) following a successful institutional placement that raised $30 million. The SPP allows eligible shareholders in Australia and New Zealand to subscribe for up to $30,000 of shares at an issue price of $2.60 per share without incurring brokerage costs. The company aims to raise approximately $2 million through the SPP, which is not underwritten. The raised funds will support manufacturing, U.S. operations expansion, sales and marketing activities, and working capital. Participation is voluntary, and applications need to be submitted via BPAY® or EFT by the closing date. The SPP is not available to shareholders located in the United States or acting on behalf of U.S. entities.
Key Points
  • SPP allows eligible shareholders to subscribe for up to $30,000 of shares without brokerage costs.
  • The issue price for SPP Shares is $2.60, the same as the institutional placement.
  • The SPP aims to raise approximately $2 million and is not underwritten.
  • Participation in the SPP is voluntary and open to eligible shareholders in Australia and New Zealand.
  • The SPP follows a successful institutional placement that raised $30 million.
  • Funds will be used for manufacturing, U.S. expansion, sales, marketing, and working capital.
  • Application for SPP Shares requires payment via BPAY® or EFT.
  • The SPP is not available to shareholders in the United States or acting for U.S. entities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.